Table 2

Feasible indicators based on diabetes recommendation statements

Reference clinical practice guideline		Population	Data source	Intervention	Data source
Primary Health Care Good Disease Management Criteria*	1	DM patients	ATC	HbA1c test twice yearly	Ana
	2	DM patients under 75 years	ATC	Low density lipoprotein (LDL) cholesterol test annually	Ana
	3	DM patients	ATC	Serum creatinine and microalbuminuria tests annually	Ana
	4	DM patients	ATC	Ophthalmologist consultation annually	TM
Gestational Diabetes Screening†	5/6‡	Pregnant women in 24–28 weeks / in the third trimester of pregnancy, if not screened earlier	DRG, Ana	Oral glucose tolerance test (OGTT) or fasting glucose test	Ana
Gestational Diabetes Screening†	7	Patients with recent history of gestational diabetes	ICD, DRG	DM screening 4–8 weeks after delivery	Ana
Recommendations Concerning Insulin Therapy for Care-dependent Patients§	8	DM patients dependent on care and insulin therapy	ATC, TM	HbA1c four times and creatinine, serum electrolytes tests 1–2 times yearly	Ana
Blood Glucose Self-Monitoring¶	9	DM patients on intensive insulin therapy	ATC	7–8 blood glucose measurements daily	MiGeL

URL links to the referenced guidelines are provided in online supplementary file 3.
*DE: Kriterien für ein ‘gutes’ Disease Management Diabetes in der Grundversorgung.
†DE: Screening des Gestationsdiabetes.
‡Two recommendation statements are combined for this indicator.
§DE: Empfehlungen bezüglich der Insulintherapie bei unselbständigen Patienten;
¶DE: Selbst-Monitoring der Blutglukose.
Ana, Analyseliste (outpatient laboratory test codes); ATC, Anatomical Therapeutic Chemical Classification System; DM, diabetes mellitus; DRG, diagnosis-related group; HbA1c, glycated haemoglobin; ICD, International Statistical Classification of Diseases and Related Health Problems, 10th revision; MiGeL, Mittel und Gegenständeliste (classification of therapeutic materials and devices); TM, TARMED Tarif (classification of outpatient procedures and services).